The U.S. orthopedic spine navigation systems market was surpassed at USD 0.21 billion in 2022 and is expected to hit around USD 0.68 billion by 2032, growing at a CAGR of 12.42% from 2023 to 2032.
Key Pointers
Report Scope of the U.S. Orthopedic Spine Navigation Systems Market
Report Coverage | Details |
Market Size in 2022 | USD 0.21 billion |
Revenue Forecast by 2032 | USD 0.68 billion |
Growth rate from 2023 to 2032 | CAGR of 12.42% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Companies Covered | B. Braun Melsungen AG; Stryker; Medtronic; Smith+Nephew; Johnson & Johnson Services, Inc. (DePuy Synthes); Zimmer Biomet; Kinamed, Inc.; Globus Medical; OrthAlign; Novarad Corp. |
Spine navigation systems are advanced medical devices that help surgeons perform spinal procedures more precisely and accurately. These systems build a three-dimensional map of the patient’s anatomy using real-time imaging and computer technology, giving the surgeon the ability to see the surgery site in real-time and make more accurate incisions. Increasing incidence of lifestyle-related health conditions, growing geriatric population, and rising number of sports & road injuries are some of the major factors contributing to the market growth.
For instance, according to the UNECE, in 2019, around 2,740,000 people were injured in road traffic accidents in the U.S. Furthermore, the prevalence of spinal disorders, such as degenerative disc disease, herniated discs, and spinal stenosis, is increasing in the U.S. population, driving the demand for orthopedic spine navigation systems. As per the National Spinal Cord Injury Statistical Center (NSCSC) 2021 estimates, approximately 30% of individuals with spinal cord injuries are re-admitted to hospitals within a year of their injury, with an average hospital stay of 22 days for those requiring readmission. Furthermore, as per an article published by the University of Washington in January 2021, traumatic spinal cord injuries affect over 18,000 Americans each year.
Many of these people require assistance with daily activities like eating, grooming, and drinking water since they are unable to use their hands or arms. However, the high cost of spinal procedures, regulatory barriers, and the lack of reimbursement policies are some of the factors restraining the growth of the market. Spine navigation systems can be expensive, and some healthcare providers may not have the resources to invest in them. According to a report by the National Spinal Cord Injury Statistical Center, the first-year expenses for a Spinal Cord Injury (SCI) with paraplegia averaged USD 537,271 in 2017. For quadriplegia, the first-year expenses were up to USD 1,102,403. The subsequent yearly expenses for paraplegia averaged USD 71,172, while for quadriplegia, the expenses could reach up to USD 191,436.
These statistics highlight the substantial financial burden that SCI can impose on individuals and society. The COVID-19 pandemic has brought about substantial changes to the medical industry, resulting in considerable challenges to regular clinical operations. The surgical navigation system market has been negatively impacted due to constraints on non-essential procedures. Nevertheless, the market is expected to grow owing to the factors, such as the rising need for improved patient outcomes, which will drive the adoption of new navigation-assisted surgical technologies. For instance, in February 2021, Royal Philips launched the ClarifEye Augmented Reality Surgical Navigation for minimally invasive spine surgeries, showcasing the continued development and introduction of innovative products to support market growth.
Technology Insights
Based on the technology, the industry has been classified into optical, electromagnetic, and others. The optical segment held the largest revenue share of 41% in 2022. This is owing to the high number of minimally invasive surgeries performed and the adoption of digital surgery solutions by end-users. Optical navigation systems can track surgical instruments using cameras and reflective markers, which provide real-time and precise guidance to surgeons during procedures. They are non-invasive and do not require additional hardware, which reduces the risk of complications and infections.
These systems are also cost-effective, making them an attractive option for healthcare providers compared to other technologies, such as electromagnetic navigation systems. The others segment comprises hybrid, CT-based, and fluoroscopy-based navigation systems. The others segment is expected to witness the fastest CAGR of 13.22% in the coming years owing to the increasing volume of orthopedic surgeries, technological advancements, availability of navigation systems for orthopedic surgeries, and R&D by key market players.
End-use Insights
The end-use segment has been bifurcated into hospitals and Ambulatory Surgery Centers (ASCs). The hospital segment held the largest share of 74% in 2022. This can be attributed to the fact that many orthopedic surgeries are performed in hospital settings. In addition, an increase in preference for minimally invasive surgeries will support segment growth. Moreover, hospitals provide specialized, long-term care to patients, and treatment costs are often reimbursed, which contributes to the segment’s growth. In December 2022, SeaSpine Holdings Corp. reported the installation of its 7D FLASH Navigation System at the Inova Fairfax Hospital in the U.S. This marked the 100th installation of the company’s 7D system across the globe.
The ASCs segment is projected to grow at the fastest CAGR of 13.63% over the forecast period. This is due to the growing number of ASCs, the adoption of enabling technologies for orthopedic surgeries, and the cost-effectiveness of ASCs. As per March 2022 estimates by the Centers for Medicare & Medicaid Services (CMS), about 461 Medicare-Certified ASCs are present in Texas, which is higher than the 442 ASCs reported in 2021. Similarly, during the same period, the number of ASCs increased from 457 to 463 in Florida, 368 to 386 in Georgia, and 817 to 845 in California. The number of ASCs is anticipated to increase with time as these facilities enable the performing of a large number of surgeries in short periods.
U.S. Orthopedic Spine Navigation Systems Market Segmentations:
By Technology
By End-use
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Orthopedic Spine Navigation Systems Market
5.1. COVID-19 Landscape: U.S. Orthopedic Spine Navigation Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Orthopedic Spine Navigation Systems Market, By Technology
8.1. U.S. Orthopedic Spine Navigation Systems Market, by Technology, 2023-2032
8.1.1. Optical
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Electromagnetic
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Orthopedic Spine Navigation Systems Market, By End-use
9.1. U.S. Orthopedic Spine Navigation Systems Market, by End-use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Ambulatory Surgical Centers (ASCs)
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Orthopedic Spine Navigation Systems Market, Regional Estimates and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Forecast, by Technology (2020-2032)
10.1.2. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 11. Company Profiles
11.1. B. Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Stryker
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Medtronic
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Smith+Nephew
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Johnson & Johnson Services, Inc. (DePuy Synthes)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Zimmer Biomet
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Kinamed, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Globus Medical
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. OrthAlign
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Novarad Corp.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms